OraSure Technologies, Inc. is a leader in the development and distribution of innovative diagnostic solutions aimed at improving healthcare access and quality. The company specializes in rapid diagnostic tests and sample collection devices that facilitate the detection of critical medical conditions, including infectious diseases such as HIV, syphilis, HCV, COVID-19, and Ebola. Their flagship products, such as the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test and the InteliSwab® COVID-19 Rapid Test, are designed for ease of use, providing accurate results in a short timeframe, often within 20 minutes. These tests are utilized in various settings, including clinical laboratories, hospitals, and community outreach programs, thereby enhancing the ability of healthcare practitioners to identify and connect individuals to necessary care.

In addition to infectious disease diagnostics, OraSure Technologies also offers a range of oral fluid-based substance abuse testing products. Their Intercept® Oral Fluid Drug Test and Q.E.D.® Saliva Alcohol Test provide reliable and efficient methods for detecting the presence of drugs and alcohol, making them suitable for workplace and clinical settings. The company’s commitment to innovation extends to its subsidiary, DNA Genotek, which focuses on optimizing sample collection for genomic research and diagnostics. Together, these technologies underscore OraSure's mission to transform health through actionable insights and improve the overall value of healthcare.

United States

OraSure Technologies developd, manufactured and distributed of point-of-care diagnostic tests, molecular collection devices. These include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick® platform; sample self-collection and stabilization products for molecular applications; and oral fluid laboratory tests for detecting various drugs of abuse. Orasure's wholly-owned subsidiaries include DNA Genotek, CoreBiome, and Novosanis.COVID-19: BARDA funded the development of a rapid coronavirus test that can be self-administered at home.

OraSure Technologies

Company Details